More IVD Clinical Trials to Receive NMPA (CFDA) Clinical Audit
The compliance with the NMPA (CFDA) clinical trial requirements in China is getting more strictly audited and reinforced. On November 13th, NMPA (CFDA) issued the 2nd notification in 2018 for